Home/Filings/4/0001213900-20-007663
4//SEC Filing

Puttagunta Sailaja 4

Accession 0001213900-20-007663

CIK 0001739174other

Filed

Mar 26, 8:00 PM ET

Accepted

Mar 27, 4:00 PM ET

Size

6.1 KB

Accession

0001213900-20-007663

Insider Transaction Report

Form 4
Period: 2020-03-25
Puttagunta Sailaja
Chief Medical Officer
Transactions
  • Award

    Common Stock Options - Right to Buy

    2020-03-25+67,50067,500 total(indirect: See Footnote)
    Exercise: $6.21Exp: 2030-03-25Common Stock (67,500 underlying)
Footnotes (3)
  • [F1]The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on March 25, 2021, and the remainder vesting in 12 equal quarterly installments over three years.
  • [F2]Does not include 263,576 additional options previously granted to the Reporting Person which have different exercise prices and which vest on different schedules.
  • [F3]The options are held by SPB Consulting LLC. The Reporting Person is the sole member of SPB Consulting LLC and may be deemed the indirect beneficial owner of the securities held by SPB Consulting LLC.

Documents

1 file

Issuer

BiomX Inc.

CIK 0001739174

Entity typeother

Related Parties

1
  • filerCIK 0001792314

Filing Metadata

Form type
4
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 4:00 PM ET
Size
6.1 KB